EP3502138
Þögul Fc tilbrigði af and-CD40 mótefnum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.11.2011EP published:
19.1.2022EP application number:
19154482.4
EP translation filed:
29.3.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
13.11.2031Expiry date:
13.11.2025Next due date:
30.11.2025
Title in English:
SILENT FC VARIANTS OF ANTI-CD40 ANTIBODIESLanguage of the patent:
English
Timeline
Today
14.11.2011EP application
19.1.2022EP Publication
29.3.2022Translation submitted
15.5.2022Registration published
13.11.2025Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Heusser, ChristophAddress:
4056 Basel, CH
Name:
Rush, JamesAddress:
4056 Basel, CH
Name:
Vincent, KarenAddress:
4056 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
41356710 PDate:
15.11.2010Country:
US
Classification
Categories:
C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 27.10.2022
Expires: 13.11.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.11.2023
Expires: 13.11.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.10.2024
Expires: 13.11.2025
Payer: Árnason Faktor ehf.